Revenue from operations grew 13% YoY to Rs 5,592 crore, compared to Rs 4,944 crore in Q4FY24.
On a sequential basis, profit after tax (PAT) rose 5% from Rs 372 crore in Q3FY25. Revenue was marginally higher by 1.2% compared to Rs 5,527 crore in the previous quarter.
Total expenses during the quarter stood at Rs 5,148 crore, up from Rs 5,060 crore in Q3FY25 and Rs 4,612 crore in Q4FY24. Key expenditure heads included cost of materials consumed, changes in inventories, employee benefits, and finance costs.
The company’s board has recommended a final dividend of Rs 10 per equity share for FY25. The record date for determining eligible shareholders has been set for August 19, 2025.
Also Read: India’s top 10 priciest stocks in 2025: MRF to Elcid, see who tops the list
Segment revenue
The company’s revenue comes from healthcare services, retail health & diagnostics and digital health & pharmacy distribution.- Healthcare services: Q4FY25 revenue stood at Rs 2,843 crore versus Rs 2,803 crore in Q3FY25 and Rs 2,579 crore in Q4FY24.
– Retail Health & Diagnostics: Q4FY25 revenue stood at Rs 394 crore versus Rs 390 crore in Q3FY25 and Rs 354 crore in Q4FY24.
– Digital health & pharmacy distribution: Q4FY25 revenue stood at Rs 2,376 versus Rs 2,352 crore in Q3FY25 and Rs 2,027 crore in Q4FY24.
The company also announced significant expansion in Bengaluru in the Sarjapur micro-market through the addition of 700 beds in 2 stages, to establish a dominant presence in the South-Eastern part of the city with a large addressable market.
Also Read: Ola Electric, Kalyan Jewellers among 10 firms where promoters pledge increased in Q4
Apollo Hospitals share price target
According to Trendlyne, the average target price for Apollo Hospitals stands at Rs 7,779, indicating a potential upside of nearly 13% from current levels. Among the 29 analysts tracking the stock, the consensus rating is ‘Buy’.
Apollo Hospitals shares are down 7% year-to-date but have gained 14% over the past three months. The company’s market capitalisation currently stands at Rs 98,897 crore.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)